Editas Wins FDA Approval for IND of CRISPR Treatment for LCA10
The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer | Signal Transduction and Targeted Therapy
CRISPR Clinical Trials to Watch for in 2022 and Beyond
Genome Editing The Future Of Drug Discovery
CRISPR to fix bad blood: a new tool in basic and clinical hematology | Haematologica
CRISPR to fix bad blood: a new tool in basic and clinical hematology | Haematologica
CRISPR-Edited Immune Cells Can Survive and Thrive After Infusion into Cancer Patients - Penn Medicine
CRISPR clinical trials for inherited diseases listed in this review. | Download Scientific Diagram
Crazy for CRISPR! | Signals Blog
IJMS | Free Full-Text | Novel CRISPR–Cas Systems: An Updated Review of the Current Achievements, Applications, and Future Research Perspectives | HTML
CRISPR-based therapeutics: The race is on - Pharmaceutical Technology
CRISPR Clinical Trials: A 2022 Update - Innovative Genomics Institute (IGI)
UC Consortium Launches First Clinical Trial Using CRISPR to Correct Gene Defect That Causes Sickle Cell Disease | UC San Francisco
The power and the promise of CRISPR/Cas9 genome editing for clinical application with gene therapy - ScienceDirect
News: CRISPR Therapy Turns a Corner With First Cures In Sight - CRISPR Medicine
First clinical trial involving in vivo CRISPR human gene editing
Enabling Discovery to Clinic Research with the Halo Platform
CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases - ScienceDirect
Eric Topol ar Twitter: "@techreview @JAMAOphth @emilylmullin @PNASNews @US_FDA @spark_tx Of the ongoing or planned #CRISPR clinical trials, 2 of 12 are for rare eye diseases https://t.co/i7GKOYTkPP" / Twitter
Phase I/II clinical trials that use CRISPR/Cas9 genome-editing technologies | Download Scientific Diagram
Frontiers | CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
How CRISPR Is Changing Cancer Research and Treatment - NCI
Gene editing drugs – clinical potential and important regulatory considerations - Biopharma Excellence
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy | Molecular Cancer | Full Text
CRISPR-Cas9 Clinical Trials as of February 2018. | Download Table
Intellia's early CRISPR trial data validate a drug pipeline and the gene-editing field - MedCity News
